TY - JOUR
T1 - EU-AIMS Longitudinal European Autism Project (LEAP)
T2 - The autism twin cohort
AU - Isaksson, Johan
AU - Tammimies, Kristiina
AU - Neufeld, Janina
AU - Cauvet, Élodie
AU - Lundin, Karl
AU - Buitelaar, Jan K.
AU - Loth, Eva
AU - Murphy, Declan G.M.
AU - Spooren, Will
AU - Bölte, Sven
AU - Ahmad, Jumana
AU - Ambrosino, Sara
AU - Auyeung, Bonnie
AU - Banaschewski, Tobias
AU - Baron-Cohen, Simon
AU - Baumeister, Sarah
AU - Beckmann, Christian
AU - Bourgeron, Thomas
AU - Bours, Carsten
AU - Brammer, Michael
AU - Brandeis, Daniel
AU - Brogna, Claudia
AU - De Bruijn, Yvette
AU - Chakrabarti, Bhismadev
AU - Charman, Tony
AU - Crawley, Daisy
AU - Cornelissen, Ineke
AU - Dell'Acqua, Flavio
AU - Dumas, Guillaume
AU - Durston, Sarah
AU - Ecker, Christine
AU - Frouin, Vincent
AU - Garcés, Pilar
AU - Goyard, David
AU - Ham, Lindsay
AU - Hayward, Hannah
AU - Hipp, Joerg
AU - Holt, Rosemary J.
AU - Johnson, Mark H.
AU - Jones, Emily J.H.
AU - Kundu, Prantik
AU - Lai, Meng Chuan
AU - D'Ardhuy, Xavier Liogier
AU - Lombardo, Michael
AU - Lythgoe, David J.
AU - Ruggeri, Barbara
AU - Cáceres, Antonia San José
AU - Simonoff, Emily
AU - Tillmann, Julian
AU - Williams, Steve C.R.
PY - 2018/4/13
Y1 - 2018/4/13
N2 - EU-AIMS is the largest European research program aiming to identify stratification biomarkers and novel interventions for autism spectrum disorder (ASD). Within the program, the Longitudinal European Autism Project (LEAP) has recruited and comprehensively phenotyped a rare sample of 76 monozygotic and dizygotic twins, discordant, or concordant for ASD plus 30 typically developing twins. The aim of this letter is to complete previous descriptions of the LEAP case-control sample, clinically characterize, and investigate the suitability of the sample for ASD twin-control analyses purposes and share some 'lessons learnt.' Among the twins, a diagnosis of ASD is associated with increased symptom levels of ADHD, higher rates of intellectual disability, and lower family income. For the future, we conclude that the LEAP twin cohort offers multiple options for analyses of genetic and shared and non-shared environmental factors to generate new hypotheses for the larger cohort of LEAP singletons, but particularly cross-validate and refine evidence from it.
AB - EU-AIMS is the largest European research program aiming to identify stratification biomarkers and novel interventions for autism spectrum disorder (ASD). Within the program, the Longitudinal European Autism Project (LEAP) has recruited and comprehensively phenotyped a rare sample of 76 monozygotic and dizygotic twins, discordant, or concordant for ASD plus 30 typically developing twins. The aim of this letter is to complete previous descriptions of the LEAP case-control sample, clinically characterize, and investigate the suitability of the sample for ASD twin-control analyses purposes and share some 'lessons learnt.' Among the twins, a diagnosis of ASD is associated with increased symptom levels of ADHD, higher rates of intellectual disability, and lower family income. For the future, we conclude that the LEAP twin cohort offers multiple options for analyses of genetic and shared and non-shared environmental factors to generate new hypotheses for the larger cohort of LEAP singletons, but particularly cross-validate and refine evidence from it.
KW - ADHD
KW - Autism spectrum disorder
KW - Biomarkers
KW - Brain
KW - Cognition
KW - Europe
KW - Genetics
KW - Intervention
KW - Twins
UR - http://www.scopus.com/inward/record.url?scp=85045403786&partnerID=8YFLogxK
U2 - 10.1186/s13229-018-0212-x
DO - 10.1186/s13229-018-0212-x
M3 - Article
AN - SCOPUS:85045403786
SN - 2040-2392
VL - 9
JO - Molecular Autism
JF - Molecular Autism
IS - 1
M1 - 26
ER -